Application 060359

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	ERYTHROCIN STEARATE	ERYTHROMYCIN STEARATE	TABLET;ORAL	EQ 250MG BASE	No	Yes
002	ERYTHROCIN STEARATE	ERYTHROMYCIN STEARATE	TABLET;ORAL	EQ 125MG BASE	No	No
003	ERYTHROCIN STEARATE	ERYTHROMYCIN STEARATE	TABLET;ORAL	EQ 500MG BASE	No	No

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
10544-594	Erythrocin Stearate	Erythromycin Stearate	Blenheim Pharmacal, Inc.	ANDA	Current
10544-595	Erythrocin Stearate	Erythromycin Stearate	Blenheim Pharmacal, Inc.	ANDA	Current
24338-106	Erythrocin Stearate	ERYTHROMYCIN STEARATE	Arbor Pharmaceuticals, Inc.	ANDA	Current
50090-0025	Erythrocin Stearate	ERYTHROMYCIN STEARATE	A-S Medication Solutions	ANDA	Current
55289-112	Erythrocin Stearate	ERYTHROMYCIN STEARATE	PD-Rx Pharmaceuticals, Inc.	ANDA	Current
55289-112	Erythrocin Stearate	ERYTHROMYCIN STEARATE	PD-Rx Pharmaceuticals, Inc.	ANDA	Current
55289-112	Erythrocin Stearate	ERYTHROMYCIN STEARATE	PD-Rx Pharmaceuticals, Inc.	ANDA	Current
55289-112	Erythrocin Stearate	ERYTHROMYCIN STEARATE	PD-Rx Pharmaceuticals, Inc.	ANDA	Current

Document, Submission type, Date table
Document	Submission type	Date
18302	SUPPL	2014-01-31